SYT ameliorates the symptoms and pathology associated with sepsis, such as pulmonary histopathological lesions in cecal ligation and puncture mice models by modulating gut microbiota [8] and improves sepsis-induced acute lung injury by regulating the ACE2-Ang (1–7)-Mas axis and inhibiting the mitogen-activated protein kinase signaling pathway [9]. This evidence concerns the gene ACE2 and Sepsis.